PubRank

Edus H Warren

Author PubWeight™ 56.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 2009 7.00
2 Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011 4.03
3 Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci Transl Med 2010 3.01
4 Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009 2.44
5 Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation. Blood 2005 2.39
6 Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood 2002 2.12
7 Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2003 1.93
8 Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation. Blood 2011 1.90
9 Evaluation of published single nucleotide polymorphisms associated with acute GVHD. Blood 2012 1.88
10 Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood 2010 1.88
11 Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia. Clin Cancer Res 2009 1.74
12 A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med 2003 1.61
13 Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens. Clin Cancer Res 2004 1.42
14 Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease. Nat Genet 2009 1.40
15 NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction. Biol Blood Marrow Transplant 2010 1.38
16 C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients. Clin Cancer Res 2008 1.20
17 The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood 2006 1.17
18 Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood 2013 1.17
19 Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Biol Blood Marrow Transplant 2009 1.09
20 Adoptive transfer of allogeneic antigen-specific T cells. Biol Blood Marrow Transplant 2006 1.04
21 DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells. Blood 2008 1.01
22 Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen. Blood 2012 0.99
23 The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation. Blood Rev 2003 0.98
24 Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation. Curr Opin Hematol 2010 0.96
25 Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling. Br J Haematol 2003 0.95
26 HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway. J Immunol 2013 0.92
27 A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403. Transplantation 2007 0.91
28 A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. J Immunol 2004 0.91
29 Applications of next-generation sequencing to blood and marrow transplantation. Biol Blood Marrow Transplant 2012 0.89
30 Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer. J Immunother 2012 0.88
31 A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011 0.86
32 Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011 0.86
33 Graft versus leukemia reactivity after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2011 0.83
34 Improving hematopoietic cell transplant outcomes in a new era of genomic research. Biol Blood Marrow Transplant 2009 0.81
35 Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient mice. PLoS One 2013 0.81
36 Abnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome. Exp Hematol 2009 0.79
37 Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after. Expert Opin Biol Ther 2011 0.77
38 CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model. J Immunother 2012 0.76